Guillaume F. Rousseau, PhD^1*, Fanny Rasschaert, PhD^1*, Mathilde Maestrali^1*, George Lardier^1*, Florent Mathieu, PhD^1*, Marie-Catherine Giarratana^1,2*, Pierre Loche^1*, François Yaya, PhD^3*, Christelle Mazurier, PhD^1*, Philippe Le Mignot^1*, Laetitia Houx^1*, Coralie Sabin^1*, Annie Viallat, PhD^3* and Luc Douay, MD^1,2

¹Erypharm, Paris, France
²Sorbonne Université, Paris, France
³CINaM, CNRS, Marseille, France

Ya-Ju Chang, PhD^1*, Niancao Chen, PhD^1*, Christine Chen^2*, Tingxia Guo, PhD^1*, Jaslem Herrera Valdez, BS^1*, Svetlana Gaidarova, MS^1*, Bryan Hancock, PhD^1*, Betsy Rezner, BS^1*, Yvonne Lentz, PhD^1*, Mark Plavsic, PhD^1*, Richard Anderson, PhD^1*, Raedun Clarke, PhD^3* and Bahram Valamehr¹

¹Fate Therapeutics, Inc., San Diego, CA
²Fate Therapeutics, San Diego, CA
³Fate Therapeutics Inc., San Diego, CA

Hiroki Kawano, MD, PhD^1*, Yuko Kawano, MD, PhD^2*, Matthew J. McArthur^3*, Laura M. Calvi, MD⁴, Satoshi Gojo^5*, Scott W. Ballinger^6*, Charles O. Smith^7*, Roman A. Eliseev^7*, Mark W. LaMere, BA^8* and Michael W. Becker, MD⁹

¹Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY
²James P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA, Rochester, NY
³Center for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester
⁴Wilmot Cancer Institute, Division of Endocrinology and Metabolism, University of Rochester Medical Center, Rochester, NY
⁵Regenerative Medicine, Kyoto Prefectural University, Kyoto
⁶Division of Molecular and Cellular Pathology, University of Alabama at Birmingham, Birmingham, AL
⁷Center for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY
⁸University of Rochester Medical Center, Rochester, NY
⁹Wilmot Cancer Institute, Division of Hematology and Oncology, University of Rochester Medical Center, Rochester, NY

Angharad Pryce^1*, Ruta Maniusyte^2*, Paul Johnson^1*, Laura Hitchinson^1*, Ann O'leary^1*, Antonio Pagliuca^1,3, Rachel Pawson^4*, Robert David Danby^1* and Chloe Anthias^5,6*

¹Anthony Nolan, London, United Kingdom
²Anthony Nolan, London, ENG, United Kingdom
³Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
⁴NHS Blood and Transplant, Oxford, United Kingdom
⁵Anthony Nolan, London, GBR
⁶Royal Marsden Hospital, Sutton, United Kingdom

Tiantian Zhang, PhD, MD^1*, Zhe Wang, Ph.D.^1*, Soung-chul Cha, PhD^1*, Aaron Anderson^1*, Jingwei Liu, MD^2*, Zhenyuan Dong, PhD^1*, Szymon Szymura, Ph.D.^1*, Benjamin Kuang, B.S.^1*, Elizabeth Oh, B.S.^1*, Sattva S. Neelapu, MD³ and Larry W. Kwak, MD, PhD⁴

¹Toni Stephenson Lymphoma Center, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX
⁴Deputy Director, City of Hope Comprehensive Cancer Center, Duarte, CA

Amany R. Keruakous, MD, MS¹, Laura Walker^2*, Molly James, MS^2*, Anand P. Jillella, MD¹, Mohammad A. H. Mian, PhD^3*, Vamsi K. Kota, MD¹ and Danielle Bradshaw, MD^1*

¹Division of Hematology/Oncology, Georgia Cancer Center at Augusta University, Augusta, GA
²Georgia Cancer Center at Augusta University, Augusta, GA
³Division of Hematology/Oncology, Georgia Cancer Center at Augusta University, Martinez, GA

Megan Melody, MD, MS¹, Madelyn Burkart, MD¹, Marcelo Villa^2*, Fenlu Zhu, PhD^1,2*, Jane N. Winter, MD¹, Reem Karmali, MD, MSc¹, Adam Yuh Lin, MD, PhD¹, Leo I. Gordon, MD¹, Kehinde Adekola, MBBS, MS¹, Jonathan Moreira, MD¹, Seema Singhal, MD^1* and Jayesh Mehta, MD^1*

¹Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
²Northwestern Medicine, Mathews Center for Cellular Therapy, Chicago, IL